Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
6 days remaining
Examiner's Amendment Completed
Due Date
July 15, 2025
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 30, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 30, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 30, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jun 30, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 30, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 14, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 14, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 14, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders
Classification
International Classes
005
016
044